カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

喘息及びCOPD治療薬の世界市場2022：ジェネリック医薬品、特許医薬品

◆英語タイトル：Global Drugs for Asthma and COPD Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22DC3788）◆商品コード：GIR22DC3788
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年1月（※2025年版があります。お問い合わせください。）
◆ページ数：118
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の喘息及びCOPD治療薬市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の喘息及びCOPD治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

喘息及びCOPD治療薬市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・ジェネリック医薬品、特許医薬品

アプリケーション別セグメントは次のように区分されます。
・喘息、COPD

世界の喘息及びCOPD治療薬市場の主要な市場プレーヤーは以下のとおりです。
・GSK、Novartis、Merck、Abbott、Boehringer Ingelheim、AstraZeneca、Roche、Teva、Vectura、Pfizer、Mylan、Allergan、Cipla、Akorn、Apotex

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、喘息及びCOPD治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な喘息及びCOPD治療薬メーカーの企業概要、2019年～2022年までの喘息及びCOPD治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な喘息及びCOPD治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別喘息及びCOPD治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの喘息及びCOPD治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での喘息及びCOPD治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および喘息及びCOPD治療薬の産業チェーンを掲載しています。
・第13、14、15章では、喘息及びCOPD治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 喘息及びCOPD治療薬の概要
– 種類別分析（2017年vs2021年vs2028年）：ジェネリック医薬品、特許医薬品
– 用途別分析（2017年vs2021年vs2028年）：喘息、COPD
– 世界の喘息及びCOPD治療薬市場規模・予測
– 世界の喘息及びCOPD治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– GSK、Novartis、Merck、Abbott、Boehringer Ingelheim、AstraZeneca、Roche、Teva、Vectura、Pfizer、Mylan、Allergan、Cipla、Akorn、Apotex
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ジェネリック医薬品、特許医薬品
・用途別分析2017年-2028年：喘息、COPD
・喘息及びCOPD治療薬の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・喘息及びCOPD治療薬のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・喘息及びCOPD治療薬のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・喘息及びCOPD治療薬の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・喘息及びCOPD治療薬の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Drugs for Asthma and COPD Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Asthma and COPD Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Generic Drugs
1.2.3 Patented Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Asthma and COPD Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Asthma
1.3.3 COPD
1.4 Global Drugs for Asthma and COPD Market Size & Forecast
1.4.1 Global Drugs for Asthma and COPD Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for Asthma and COPD Sales in Volume (2017-2028)
1.4.3 Global Drugs for Asthma and COPD Price (2017-2028)
1.5 Global Drugs for Asthma and COPD Production Capacity Analysis
1.5.1 Global Drugs for Asthma and COPD Total Production Capacity (2017-2028)
1.5.2 Global Drugs for Asthma and COPD Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Asthma and COPD Market Drivers
1.6.2 Drugs for Asthma and COPD Market Restraints
1.6.3 Drugs for Asthma and COPD Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Drugs for Asthma and COPD Product and Services
2.1.4 GSK Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Drugs for Asthma and COPD Product and Services
2.2.4 Novartis Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Drugs for Asthma and COPD Product and Services
2.3.4 Merck Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Drugs for Asthma and COPD Product and Services
2.4.4 Abbott Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Drugs for Asthma and COPD Product and Services
2.5.4 Boehringer Ingelheim Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Drugs for Asthma and COPD Product and Services
2.6.4 AstraZeneca Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Drugs for Asthma and COPD Product and Services
2.7.4 Roche Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva
2.8.1 Teva Details
2.8.2 Teva Major Business
2.8.3 Teva Drugs for Asthma and COPD Product and Services
2.8.4 Teva Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Vectura
2.9.1 Vectura Details
2.9.2 Vectura Major Business
2.9.3 Vectura Drugs for Asthma and COPD Product and Services
2.9.4 Vectura Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Drugs for Asthma and COPD Product and Services
2.10.4 Pfizer Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business
2.11.3 Mylan Drugs for Asthma and COPD Product and Services
2.11.4 Mylan Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Allergan
2.12.1 Allergan Details
2.12.2 Allergan Major Business
2.12.3 Allergan Drugs for Asthma and COPD Product and Services
2.12.4 Allergan Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business
2.13.3 Cipla Drugs for Asthma and COPD Product and Services
2.13.4 Cipla Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Akorn
2.14.1 Akorn Details
2.14.2 Akorn Major Business
2.14.3 Akorn Drugs for Asthma and COPD Product and Services
2.14.4 Akorn Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Apotex
2.15.1 Apotex Details
2.15.2 Apotex Major Business
2.15.3 Apotex Drugs for Asthma and COPD Product and Services
2.15.4 Apotex Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for Asthma and COPD Breakdown Data by Manufacturer
3.1 Global Drugs for Asthma and COPD Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for Asthma and COPD Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for Asthma and COPD
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Asthma and COPD Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for Asthma and COPD Manufacturer Market Share in 2021
3.5 Global Drugs for Asthma and COPD Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for Asthma and COPD Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for Asthma and COPD Market Size by Region
4.1.1 Global Drugs for Asthma and COPD Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for Asthma and COPD Revenue by Region (2017-2028)
4.2 North America Drugs for Asthma and COPD Revenue (2017-2028)
4.3 Europe Drugs for Asthma and COPD Revenue (2017-2028)
4.4 Asia-Pacific Drugs for Asthma and COPD Revenue (2017-2028)
4.5 South America Drugs for Asthma and COPD Revenue (2017-2028)
4.6 Middle East and Africa Drugs for Asthma and COPD Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for Asthma and COPD Sales in Volume by Type (2017-2028)
5.2 Global Drugs for Asthma and COPD Revenue by Type (2017-2028)
5.3 Global Drugs for Asthma and COPD Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for Asthma and COPD Sales in Volume by Application (2017-2028)
6.2 Global Drugs for Asthma and COPD Revenue by Application (2017-2028)
6.3 Global Drugs for Asthma and COPD Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for Asthma and COPD Sales by Type (2017-2028)
7.2 North America Drugs for Asthma and COPD Sales by Application (2017-2028)
7.3 North America Drugs for Asthma and COPD Market Size by Country
7.3.1 North America Drugs for Asthma and COPD Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for Asthma and COPD Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for Asthma and COPD Sales by Type (2017-2028)
8.2 Europe Drugs for Asthma and COPD Sales by Application (2017-2028)
8.3 Europe Drugs for Asthma and COPD Market Size by Country
8.3.1 Europe Drugs for Asthma and COPD Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for Asthma and COPD Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for Asthma and COPD Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for Asthma and COPD Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for Asthma and COPD Market Size by Region
9.3.1 Asia-Pacific Drugs for Asthma and COPD Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for Asthma and COPD Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for Asthma and COPD Sales by Type (2017-2028)
10.2 South America Drugs for Asthma and COPD Sales by Application (2017-2028)
10.3 South America Drugs for Asthma and COPD Market Size by Country
10.3.1 South America Drugs for Asthma and COPD Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for Asthma and COPD Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for Asthma and COPD Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for Asthma and COPD Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for Asthma and COPD Market Size by Country
11.3.1 Middle East & Africa Drugs for Asthma and COPD Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for Asthma and COPD Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for Asthma and COPD and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for Asthma and COPD
12.3 Drugs for Asthma and COPD Production Process
12.4 Drugs for Asthma and COPD Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for Asthma and COPD Typical Distributors
13.3 Drugs for Asthma and COPD Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drugs for Asthma and COPD Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for Asthma and COPD Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Drugs for Asthma and COPD Product and Services
Table 6. GSK Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Drugs for Asthma and COPD Product and Services
Table 10. Novartis Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Drugs for Asthma and COPD Product and Services
Table 14. Merck Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Drugs for Asthma and COPD Product and Services
Table 18. Abbott Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Drugs for Asthma and COPD Product and Services
Table 22. Boehringer Ingelheim Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Drugs for Asthma and COPD Product and Services
Table 26. AstraZeneca Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Roche Basic Information, Manufacturing Base and Competitors
Table 28. Roche Major Business
Table 29. Roche Drugs for Asthma and COPD Product and Services
Table 30. Roche Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Teva Basic Information, Manufacturing Base and Competitors
Table 32. Teva Major Business
Table 33. Teva Drugs for Asthma and COPD Product and Services
Table 34. Teva Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Vectura Basic Information, Manufacturing Base and Competitors
Table 36. Vectura Major Business
Table 37. Vectura Drugs for Asthma and COPD Product and Services
Table 38. Vectura Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Drugs for Asthma and COPD Product and Services
Table 42. Pfizer Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan Drugs for Asthma and COPD Product and Services
Table 46. Mylan Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Allergan Basic Information, Manufacturing Base and Competitors
Table 48. Allergan Major Business
Table 49. Allergan Drugs for Asthma and COPD Product and Services
Table 50. Allergan Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Cipla Basic Information, Manufacturing Base and Competitors
Table 52. Cipla Major Business
Table 53. Cipla Drugs for Asthma and COPD Product and Services
Table 54. Cipla Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Akorn Basic Information, Manufacturing Base and Competitors
Table 56. Akorn Major Business
Table 57. Akorn Drugs for Asthma and COPD Product and Services
Table 58. Akorn Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Apotex Basic Information, Manufacturing Base and Competitors
Table 60. Apotex Major Business
Table 61. Apotex Drugs for Asthma and COPD Product and Services
Table 62. Apotex Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Drugs for Asthma and COPD Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 64. Global Drugs for Asthma and COPD Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Drugs for Asthma and COPD, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Drugs for Asthma and COPD Production Capacity by Company, (MT): 2020 VS 2021
Table 67. Head Office and Drugs for Asthma and COPD Production Site of Key Manufacturer
Table 68. Drugs for Asthma and COPD New Entrant and Capacity Expansion Plans
Table 69. Drugs for Asthma and COPD Mergers & Acquisitions in the Past Five Years
Table 70. Global Drugs for Asthma and COPD Sales by Region (2017-2022) & (MT)
Table 71. Global Drugs for Asthma and COPD Sales by Region (2023-2028) & (MT)
Table 72. Global Drugs for Asthma and COPD Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Drugs for Asthma and COPD Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 75. Global Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 76. Global Drugs for Asthma and COPD Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Drugs for Asthma and COPD Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Drugs for Asthma and COPD Price by Type (2017-2022) & (USD/Kg)
Table 79. Global Drugs for Asthma and COPD Price by Type (2023-2028) & (USD/Kg)
Table 80. Global Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 81. Global Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 82. Global Drugs for Asthma and COPD Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Drugs for Asthma and COPD Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Drugs for Asthma and COPD Price by Application (2017-2022) & (USD/Kg)
Table 85. Global Drugs for Asthma and COPD Price by Application (2023-2028) & (USD/Kg)
Table 86. North America Drugs for Asthma and COPD Sales by Country (2017-2022) & (MT)
Table 87. North America Drugs for Asthma and COPD Sales by Country (2023-2028) & (MT)
Table 88. North America Drugs for Asthma and COPD Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Drugs for Asthma and COPD Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 91. North America Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 92. North America Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 93. North America Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 94. Europe Drugs for Asthma and COPD Sales by Country (2017-2022) & (MT)
Table 95. Europe Drugs for Asthma and COPD Sales by Country (2023-2028) & (MT)
Table 96. Europe Drugs for Asthma and COPD Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Drugs for Asthma and COPD Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 99. Europe Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 100. Europe Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 101. Europe Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 102. Asia-Pacific Drugs for Asthma and COPD Sales by Region (2017-2022) & (MT)
Table 103. Asia-Pacific Drugs for Asthma and COPD Sales by Region (2023-2028) & (MT)
Table 104. Asia-Pacific Drugs for Asthma and COPD Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Drugs for Asthma and COPD Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 107. Asia-Pacific Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 108. Asia-Pacific Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 109. Asia-Pacific Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 110. South America Drugs for Asthma and COPD Sales by Country (2017-2022) & (MT)
Table 111. South America Drugs for Asthma and COPD Sales by Country (2023-2028) & (MT)
Table 112. South America Drugs for Asthma and COPD Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Drugs for Asthma and COPD Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 115. South America Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 116. South America Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 117. South America Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 118. Middle East & Africa Drugs for Asthma and COPD Sales by Region (2017-2022) & (MT)
Table 119. Middle East & Africa Drugs for Asthma and COPD Sales by Region (2023-2028) & (MT)
Table 120. Middle East & Africa Drugs for Asthma and COPD Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Drugs for Asthma and COPD Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 123. Middle East & Africa Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 124. Middle East & Africa Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 125. Middle East & Africa Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 126. Drugs for Asthma and COPD Raw Material
Table 127. Key Manufacturers of Drugs for Asthma and COPD Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Drugs for Asthma and COPD Typical Distributors
Table 131. Drugs for Asthma and COPD Typical Customers
List of Figures
Figure 1. Drugs for Asthma and COPD Picture
Figure 2. Global Drugs for Asthma and COPD Revenue Market Share by Type in 2021
Figure 3. Generic Drugs
Figure 4. Patented Drugs
Figure 5. Global Drugs for Asthma and COPD Revenue Market Share by Application in 2021
Figure 6. Asthma
Figure 7. COPD
Figure 8. Global Drugs for Asthma and COPD Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 9. Global Drugs for Asthma and COPD Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Drugs for Asthma and COPD Sales (2017-2028) & (MT)
Figure 11. Global Drugs for Asthma and COPD Price (2017-2028) & (USD/Kg)
Figure 12. Global Drugs for Asthma and COPD Production Capacity (2017-2028) & (MT)
Figure 13. Global Drugs for Asthma and COPD Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Drugs for Asthma and COPD Market Drivers
Figure 15. Drugs for Asthma and COPD Market Restraints
Figure 16. Drugs for Asthma and COPD Market Trends
Figure 17. Global Drugs for Asthma and COPD Sales Market Share by Manufacturer in 2021
Figure 18. Global Drugs for Asthma and COPD Revenue Market Share by Manufacturer in 2021
Figure 19. Drugs for Asthma and COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Drugs for Asthma and COPD Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Drugs for Asthma and COPD Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Drugs for Asthma and COPD Sales Market Share by Region (2017-2028)
Figure 23. Global Drugs for Asthma and COPD Revenue Market Share by Region (2017-2028)
Figure 24. North America Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 25. Europe Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 27. South America Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 29. Global Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 30. Global Drugs for Asthma and COPD Revenue Market Share by Type (2017-2028)
Figure 31. Global Drugs for Asthma and COPD Price by Type (2017-2028) & (USD/Kg)
Figure 32. Global Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 33. Global Drugs for Asthma and COPD Revenue Market Share by Application (2017-2028)
Figure 34. Global Drugs for Asthma and COPD Price by Application (2017-2028) & (USD/Kg)
Figure 35. North America Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 36. North America Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 37. North America Drugs for Asthma and COPD Sales Market Share by Country (2017-2028)
Figure 38. North America Drugs for Asthma and COPD Revenue Market Share by Country (2017-2028)
Figure 39. United States Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 43. Europe Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 44. Europe Drugs for Asthma and COPD Sales Market Share by Country (2017-2028)
Figure 45. Europe Drugs for Asthma and COPD Revenue Market Share by Country (2017-2028)
Figure 46. Germany Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Drugs for Asthma and COPD Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Drugs for Asthma and COPD Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drugs for Asthma and COPD Revenue Market Share by Region (2017-2028)
Figure 55. China Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 62. South America Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 63. South America Drugs for Asthma and COPD Sales Market Share by Country (2017-2028)
Figure 64. South America Drugs for Asthma and COPD Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Drugs for Asthma and COPD Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Drugs for Asthma and COPD Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Drugs for Asthma and COPD in 2021
Figure 76. Manufacturing Process Analysis of Drugs for Asthma and COPD
Figure 77. Drugs for Asthma and COPD Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

※参考情報

喘息や慢性閉塞性肺疾患（COPD）は、呼吸器系に影響を与える疾患であり、これらの治療にはさまざまな薬剤が使用されます。これらの薬剤は患者の症状を軽減し、日常生活の質を向上させるために重要な役割を果たしています。

まず、喘息とは、気道の炎症によって引き起こされる慢性的な疾患で、咳、喘鳴（呼吸時のひゅうひゅう音）、息切れなどの症状を伴います。一方、COPDは主に喫煙によって引き起こされる慢性の肺疾患で、気道の狭窄と肺の弾力性の低下が特徴です。どちらの疾患においても、肺機能が低下することで、酸素の取り込みや二酸化炭素の排出が障害されることがあるため、早期の治療が必要です。

喘息およびCOPDの治療に使用される薬剤は大きく分けて、長期管理薬と救急用薬の二つに分類されます。長期管理薬は、炎症を抑えることに重点を置いており、定期的な使用が推奨されています。代表的なものには、吸入ステロイド剤やロイコトリエン受容体拮抗薬が含まれます。これらの薬剤は気道の炎症を軽減し、症状のコントロールに寄与します。

吸入ステロイド剤は、気道の炎症を抑える作用が強く、喘息やCOPDにおいて最も広く使用されています。主な成分には、フルチカゾン、ブデソニド、モメタゾンなどがあります。これらの薬剤は、定期的に吸入することで気道の炎症を抑え、長期的な症状の改善が期待できます。

ロイコトリエン受容体拮抗薬は、気道の平滑筋を弛緩させたり、炎症反応を抑えることで症状を軽減します。モンテルカストが代表的な薬剤で、特に喘息において多くの患者に使用されています。また、アレルギーや季節性の喘息に対しても効果があります。

救急用薬は、急性の症状発作時に迅速に効果を発揮することが求められます。短時間作用型β2刺激薬（SABA）が代表的で、例としてはサルブタモールやメトプロテロールがあります。これらの薬剤は気道を拡げる効果があり、発作時の迅速な緩和が期待されます。これに対して、長時間作用型β2刺激薬（LABA）は、より長い時間効果が持続し、長期管理に使用されます。

さらに、COPDの治療においては、抗コリン薬も重要な役割を果たしています。これらの薬剤は気道平滑筋を弛緩させることで、気道の閉塞を改善します。短時間作用型抗コリン薬としては、イブプロフィウムがあり、長時間作用型の代表にはチオトロピウムがあります。特にCOPDの患者においては、これらの抗コリン薬が呼吸機能を改善し、生活の質を向上させるために有効です。

最近では、生物製剤も喘息やCOPDの治療において注目を集めています。特に、好酸球性喘息の患者に対しては、IL-5受容体拮抗薬などが効果的です。これらの薬剤は特定の生物学的経路をターゲットにしており、個別化医療の一環としての役割を果たします。

治療において用いられるテクニックとしては、吸入技術の指導が重要です。吸入薬の効果を最大限に引き出すためには、正しい吸入が不可欠です。そのため、医療従事者は患者への指導を行い、吸入デバイスの使い方を確認します。特に、小児や高齢者においては、適切な技術が習得されていないと、薬剤の効果が十分に発揮されない場合があります。

また、喘息やCOPDの治療には、生活習慣の改善や環境要因の管理も不可欠です。喫煙はCOPDの主要な原因であり、禁煙は最も重要な治療の一部とされています。また、アレルゲンの除去や環境の改善も、症状のコントロールには重要な要素です。

喘息およびCOPDの管理は、薬物療法だけでなく、自己管理教育や定期的なフォローアップも含まれます。患者が自分の病気を理解し、適切な行動を取ることができるようなサポートが求められます。例えば、症状が悪化した際の対処法や、薬の使用頻度と効果の観察などについての教育が重要です。

また、関係する技術として、遠隔医療やモニタリング技術の発展も挙げられます。これにより、患者は自宅でコンディションを自己管理しやすくなり、医療従事者もリアルタイムでのデータを利用して、より適切な治療を提供することが可能となります。

喘息とCOPDは、いずれも慢性的な疾患であり、長期的なケアと管理が不可欠です。薬物治療の選択や生活習慣の改善、定期的な医療機関でのフォローにより、患者の症状を軽減し、生活の質を向上させることが目指されます。医療チームと患者が協働して、最適な治療戦略を立てることが、これらの疾患の管理において非常に重要です。これにより、患者はより良い生活を送ることができ、自身の健康を積極的に管理していくことが可能となります。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 喘息及びCOPD治療薬の世界市場2022：ジェネリック医薬品、特許医薬品(Global Drugs for Asthma and COPD Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 処方薬の世界市場2022：先発医薬品、ジェネリック医薬品
  • 喘息＆COPD治療薬の世界市場2023年～2030年：疾患別、薬効分類別、地域別
  • 喘息＆COPD治療薬の世界市場見通し2023年-2029年
  • 喘息＆COPD治療の世界市場2023〜2033
  • MSD医薬品のグローバル市場2025年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆